Posted inClinical Updates Wellness & Lifestyle
Automated Insulin Delivery in Young Children with Type 1 Diabetes: Insights from the LENNY Trial
The LENNY trial demonstrates that the MiniMed 780G automated insulin delivery system improves glycaemic control and maintains safety in children aged 2–6 years with type 1 diabetes.